Clinical potential of proteomics in the diagnosis of ovarian cancer
- 1 July 2002
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Molecular Diagnostics
- Vol. 2 (4) , 312-320
- https://doi.org/10.1586/14737159.2.4.312
Abstract
The need for specific and sensitive markers of ovarian cancer is critical. Finding a sensitive and specific test for its detection has an important public health impact. Currently, there are no eff...Keywords
This publication has 21 references indexed in Scilit:
- Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous LeukemiaNew England Journal of Medicine, 2002
- Three-Dimensional Power Doppler Ultrasound Improves the Diagnostic Accuracy for Ovarian Cancer PredictionGynecologic Oncology, 2001
- The Sequence of the Human GenomeScience, 2001
- Initial sequencing and analysis of the human genomeNature, 2001
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- Immuno-LCM: Laser Capture Microdissection of Immunostained Frozen Sections for mRNA AnalysisThe American Journal of Pathology, 1999
- THE GENETICS OF BREAST CANCER SUSCEPTIBILITYAnnual Review of Genetics, 1998
- Transvaginal Sonography as a Screening Method for the Detection of Early Ovarian CancerGynecologic Oncology, 1997
- Expression profiles of active genes in human and mouse liversGene, 1996
- Unusual case of Smith‐Lemli‐Opitz syndrome “type II”American Journal of Medical Genetics, 1995